Advertisement
Canada markets close in 4 hours 20 minutes

  • S&P/TSX

    21,828.70
    +120.26 (+0.55%)
     

  • S&P 500

    4,996.01
    -15.11 (-0.30%)
     

  • DOW

    37,965.16
    +189.78 (+0.50%)
     

  • CAD/USD

    0.7277
    +0.0014 (+0.19%)
     

  • CRUDE OIL

    82.98
    +0.25 (+0.30%)
     

  • Bitcoin CAD

    88,751.94
    +1,188.65 (+1.36%)
     

  • CMC Crypto 200

    1,374.89
    +62.26 (+4.98%)
     

  • GOLD FUTURES

    2,408.00
    +10.00 (+0.42%)
     

  • RUSSELL 2000

    1,946.05
    +3.09 (+0.16%)
     

  • 10-Yr Bond

    4.6170
    -0.0300 (-0.65%)
     

  • NASDAQ

    15,438.70
    -162.80 (-1.04%)
     

  • VOLATILITY

    18.65
    +0.65 (+3.61%)
     

  • FTSE

    7,893.43
    +16.38 (+0.21%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6820
    -0.0001 (-0.01%)
     
MARKETS LIVE BLOG:

STOCKS TRADE MIXED AFTER ISRAEL STRIKE-FUELLED TUMBLE

Apple pulls WhatsApp and Threads from China App Store

Valeant won't pay whatever it takes for Allergan: CEO

Reuters

(Reuters) - Valeant Pharmaceuticals Inc won't pay whatever it takes to acquire rival Allergan Inc, and it will not turn its bid into an all-cash deal, Valeant Chief Executive Michael Pearson said on Tuesday in New York. Valeant and activist investor Bill Ackman made an unsolicited $47 billion bid to buy Botox maker Allergan as it seeks to become one of the world's five biggest drug companies. (Reporting by Bill Berkrot in New York; Writing by Rod Nickel in Winnipeg, Manitoba; Editing by Meredith Mazzilli)